Oxidation products and antioxidant markers in plasma of patients with Graves' disease and toxic multinodular goiter: Effect of methimazole treatment

Free Radical Research

Volumn 38, Issue 6, 2004, Pages 659-664

  Bednarek, Janusz ^a   Wysocki, Henryk ^a   Sowinski, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antioxidants; Graves' disease; Methimazole; Oxidative stress; Plasma; Toxic multinodular goiter

Indexed keywords

ANTIOXIDANT; ANTITHYROID AGENT; BIOCHEMICAL MARKER; CATALASE; CERULOPLASMIN; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; LEVOTHYROXINE; LIPID HYDROPEROXIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; THIAMAZOLE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGE; AUTOIMMUNITY; BIOSYNTHESIS; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE DURATION; ENDOCRINE OPHTHALMOPATHY; ENZYME ACTIVITY; ENZYME ASSAY; EUTHYROIDISM; FEMALE; GENDER; GRAVES DISEASE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERTHYROIDISM; MALE; METABOLISM; OXIDATION; OXIDATIVE STRESS; REVIEW; SCAVENGING SYSTEM; STATISTICAL SIGNIFICANCE; THYROID FUNCTION; TOXIC GOITER; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIOXIDANTS; ANTITHYROID AGENTS; BIOLOGICAL MARKERS; FEMALE; FREE RADICALS; GOITER, NODULAR; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; MIDDLE AGED; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SEX FACTORS;

FELIS CATUS;

EID: 2542553374     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760410001701621     Document Type: Review

References (36)

1. Asayama, K., Dobashi, K., Hayashibe, H., Megata, Y. and Kato, K. (1991) "Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism", Endocrinology 121, 2112-2118.
2. Fernandez, V., Barrientos, X., Kipreos, K., Valenzuela, A. and Videla, L.A. (1985) "Superoxide radical generation, NADPH oxidase activity and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation", Endocrinology 117, 496-501.
3. Asayama, K. and Kato, K. (1990) "Oxidative muscular injury and its relevance to hyperthyroidism", Free Radic. Biol. Med. 8, 293-303.
4. Greenspan, F.S. (1997) "The thyroid gland", In: Greenspan, F.S. and Gordon, J.S., eds, Basic and Clinical Endocrinology (Prentice-Hall), pp 233-242.
5. Mariotti, S. and Pinchera, A. (1990) "Role of the immune system in the control of the thyroid function", In: Greer, M.A., ed., The Thyroid Gland (Raven Press, New York), pp 45-60.
6. Ahsan, H., Ali, A. and Ali, R. (2003) "Oxygen free radicals and systemic autoimmunity", Clin. Exp. Immunol. 131, 398-404.
7. Weetman, A.P., Holt, M.E., Campbell, A.K., Hall, R. and McGregor, A.M. (1984) "Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression", Br. Med. J. (Clin. Res. Ed.) 288, 518-520.
8. Szabo, J., Foris, G., Mezosi, E., Nagy, E.V., Paragh, G., Sztojka, I. and Leovey, A. (1996) "Parameters of respiratory burst and arachidonic acid metabolism in polymorphonuclear granulocytes from patients with various thyroid diseases", Exp. Clin. Endocrinol. Diabetes 104, 172-176.
9. Wilson, R., Buchanan, L., Fraser, W.D., Jenkins, C., Smith, W.E., Reglinski, J., Thomson, J.A. and McKillop, J.H. (1998) " Evidence for carbimazole as an antioxidant?", Autoimmunity 27, 149-153.
10. Ozdem, S., Aliciguzel, Y., Ozdem, S.S. and Karayalcin, U. (2000) "Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients", Pharmacology 61, 31-36.
11. Bianchi, G., Solaroli, E. and Zaccheroni, V. (1999) "Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment", Horm. Metab. Res. 31, 620-624.
12. Wilson, R., McKillop, J.H., Chopra, M. and Thomson, J.A. (1988) "The effect of antithyroid drugs on B and T cell activity in vitro", Clin. Endocrinol. (Oxf) 28, 389-397.
13. Komosinska-Vassev, K., Olczyk, K., Kucharz, E.J., Marcisz, C., Winsz-Szczotka, K. and Kotulska, A. (2000) "Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy", Clin. Chim. Acta 300, 107-117.
14. Aliciguzel, Y., Ozdem, S.N., Ozdem, S.S., Karayalcin, U., Siedlak, S.L., Perry, G. and Smith, M.A. (2001) "Erythrocyte, plasma, and serum antioxidant activities in untreated toxic multinodular goiter patients", Free Radic. Biol. Med. 30, 665-670.
15. 2 and 3,3′,5,5′ -tetramethylbenzidine", J. Clin. Chem. Clin. Biochem. 23, 453-460.
16. Nourooz-Zadeh, J., Tajaddini-Sarmadi, J. and Wolff, S.P. (1994) "Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine", Anal. Biochem. 220, 403-409.
17. Buege, J.A. and Aust, S.D. (1978) "Microsomal lipid peroxidation", Methods Enzymol. 52, 302-310.
18. Roos, D., Weening, R.S., Voetman, A.A., van Schaik, M.L., Bot, A.A., Meerhof, L.J. and Loos, J.A. (1979) "Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency", Blood 53, 851-866.
19. Goth, L. (1991) "A simple method for determination of serum catalase activity and revision of reference range", Clin. Chim. Acta 196, 143-151.
20. Ravin, H.A. (1961) "An improved colorimetric enzymatic assay of ceruloplasmin", J. Lab. Clin. Med. 58, 161-168.
21. Sunthanthiran, M., Solomon, S.D., Williams, P.S., Rubin, A.L., Novogrodsky, A. and Stenzel, K.H. (1984) "Hydroxyl radical scavengers inhibit human cultured follicular thyroid cells", Nature 307, 276-278.
22. Taylor, J.J., Wilson, R.L. and Kendall-Taylor, P. (1984) "Evidence for direct interaction between methimazole and free radicals", FEBS Letters 176, 337-340.
23. Weetman, A.P. (1986) "Effect of the antithyroid drug methimazole on interleukin-1 and interleukin-2 levels in vitro", Clin. Endocrinol. 25, 133-142.
24. Whiteman, M. and Halliwell, B. (1997) "Thiourea and dimethylthiourea inhibit peroxynitrite-dependent damage: nonspecifity as hydroxyradical scavengers", Free Radic. Biol. Med. 22, 1309-1312.
25. Seven, R., Gelisgen, R., Seven, A., Erbil, Y., Bozbora, A. and Burcak, G. (2001) "Influence of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients", J. Toxicol. Environ. Health, Part A 62, 495-503.
26. Guerra, L.N., Moiguer, S., Karner, M., de Molina, M.C., Sreider, C.M. and Burdman, J.A. (2001) "Antioxidants in the treatment of Graves' disease", IUBMB Life 51, 105-109.
27. Halliwell, B. and Gutteridge, J.M. (1990) "Role of free radicals in human disease: an overview", Methods Enzymol. 186, 1-85.
28. Pareira, B., Costa Rosa, L., Safi, D., Bechara, E. and Curi, R. (1994) "Control of superoxide dismutase, catalase and glutathione peroxidase activities in lymphoid organs by thyroid hormones", J. Endocrinol. 140, 73-77.
29. Hara, H., Ban, Y. and Sato, R. (1993) "Serum superoxide dismutase in patients with Graves' disease", Nippon Naibunpi Gakkai Zasshi 69, 87-92.
30. Abalovich, M., Llesuy, S., Gutierrez, S. and Repetto, M. (2003) "Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments", Clin. Endocrinol. 59, 321-327.
31. Clemens, M.C. and Waller, H.D. (1987) "Lipid peroxidation in erythrocytes", Chem. Phys. Lipids 45, 251-268.
32. Seven, A., Seymen, O., Hatemi, S., Hatemi, H., Yigit, G. and Candan, G. (1996b) "Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation", Clin. Chim. Acta 256, 65-74.
33. Maral, J., Puget, K. and Michelson, A.M. (1977) "Comparative study of superoxide dismutase activity, catalase and glutathione peroxidase levels in erythrocytes of different animals", Biochem. Biophys. Res. Commun. 77, 1525-1535.
34. Ademoglu, E., Gokkusu, C., Yarman, S. and Azizlerli, H. (1998) "The effect of methimazole on the oxidant and antioxidant system in patients with hyperthyroidism", Pharmacol. Res. 38, 93-96.
35. Dumitriu, L., Bartoc, R., Ursu, H., Purice, M. and Ionescu, V. (1988) "Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism", Endocrinologie 26, 35-38.
36. Erkilic, A.B., Aliciguzel, Y., Erkilic, M. and Aksu, A. (1996) "Ceruloplasmin and vitamin E levels in toxic multinodular goiter", Nutr. Res. 6, 185-189.